Simplex Trading’s Microbot Medical MBOT Stock Holding History

Simplex Trading’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$86K	Sell	44,100 -12,400	-22%	-$25.3K	﹤0.01%	5741
2026 Q1	$136K	Sell	56,500 -130,600	-70%	-$292K	﹤0.01%	4736
2025 Q4	$374K	Sell	187,100 -196,900	-51%	-$466K	﹤0.01%	3597
2025 Q3	$1.17M	Buy	384,000 +144,300	+60%	+$450K	﹤0.01%	2894
2025 Q2	$604K	Buy	239,700 +166,400	+227%	+$398K	﹤0.01%	3302
2025 Q1	$110K	Buy	+73,300	New	+$130K	﹤0.01%	4961
2024 Q1	–	Sell	-800	Closed	-$1K	–	9429
2023 Q4	$1K	Buy	+800	New	+$1.06K	﹤0.01%	8520
2023 Q3	–	Sell	-1,300	Closed	-$3K	–	9344
2023 Q2	$3K	Buy	+1,300	New	+$2.6K	﹤0.01%	8237

Other funds holding MBOT

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Simplex Trading's MBOT Position: Q2 2026 in Review

Simplex Trading reduced its Microbot Medical (MBOT) stake by 45% in Q2 2026, selling an estimated $50.3K and leaving 30,189 shares worth $58.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6139.

Simplex Trading first reported a position in MBOT in Q1 2023 and has held it in 6 quarters since. The position peaked at $142K in Q4 2025. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

Simplex Trading held 30,189 shares of Microbot Medical worth $58.9K as of Q2 2026.
Simplex Trading sold 24,653 Microbot Medical shares in Q2 2026, an estimated $50.3K.
Microbot Medical made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6139 holding.
Simplex Trading first reported a position in Microbot Medical in Q1 2023 and has held it in 6 quarters since.
Simplex Trading's Microbot Medical position peaked at $142K in Q4 2025.
71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.